Abnormal MYC genes lead to uncontrollable MYC expression in malignant tumors because of dysfunction and translocation among Burkitt lymphoma, cervical cancer, colon cancer, breast cancer, stomach cancer, and lung cancer, especially in the pathogenesis of B-cell lymphoma, which plays an important role [9,10]. Here, MYC is linked to breast cancer.